基础医学与临床 ›› 2011, Vol. 31 ›› Issue (10): 1161-1164.

• 短篇综述 • 上一篇    下一篇

帕金森病与ATP13A2基因的研究进展

梁卉1,邓昊1,郑文2   

  1. 1. 中南大学湘雅三医院医学实验中心
    2. 中南大学湘雅三医院神经内科
  • 收稿日期:2010-04-29 修回日期:2010-09-13 出版日期:2011-10-05 发布日期:2011-10-08
  • 通讯作者: 邓昊 E-mail:denghao0008@hotmail.com
  • 基金资助:
    国家自然科学基金

Parkinson’s disease and advances in ATP13A2 gene research

  • Received:2010-04-29 Revised:2010-09-13 Online:2011-10-05 Published:2011-10-08

摘要: 帕金森病(Parkinson’s disease, PD)是一种患病率仅次于老年痴呆,年龄相关的神经退行性疾病,环境因素与遗传因素共同参与PD的发病。目前已定位16个基因位点并克隆了11个致病基因,其中位于PARK9上的ATP13A2基因与Kufor-Rakeb综合征(Kufor-Rakeb syndrome, KRS)和早发型帕金森病(Early-onset Parkinson’s disease, EOPD)相关。本文将对PD患者中ATP13A2基因突变和功能研究进行综述。

关键词: 帕金森病 , Kufor –Rakeb综合征 , EOPD , ATP13A2基因 , 金属阳离子

Abstract: Parkinson’s disease (PD) is the second most frequent neurodegenerative disease after Alzheimer’s disease, with the cause is the co-activation of environmental and genetic factors. Sixteen gene loci and 11 disease genes have been identified. ATP13A2 gene located on PARK9 implicated in Kufor-Rakeb syndrome (KRS)and early-onset Parkinson’s disease(EOPD). This review will describe the advances concerning the ATP13A2 mutations in PD patients and function of this gene.

Key words: Parkinson’s disease, Kufor-Rakeb syndrome, EOPD, the ATP13A2 gene, metal cations

中图分类号: